Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access April 8, 2011

Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?

  • Hyung Han EMAIL logo , Sae Choi , Wan Kim , Tae Song and Sang Choi
From the journal Open Medicine


A 64-year-old man with a history of gallstones, common bile duct stones, chronic hepatitis B virus infection, and hepatic cirrhosis with a Child-Pugh score B was satisfactorily treated for hepatocellular carcinoma with radiofrequency ablation and transarterial chemoembolization. His course, however, was complicated by gallbladder actinomycosis 14 months after treatment, resulting in acute cholecystitis. Such a chain of events suggests that gallbladder actinomycosis may develop after radiofrequency ablation and transarterial chemoembolization in patients who are known to have gallstones and that asymptomatic gallstones should be treated before the application of nonsurgical, but invasive procedures for hepatocellular carcinoma.

[1] Russo T. Agents of actinomycosis. In Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. New York: Churchill-Livingstone, 2000. pp. 2645–2654 Search in Google Scholar

[2] Charalabopoulos K, Charalabopoulos AK, Papalimneou V, et al. Lung, pleural and colon actinomycosis in an immunocompromised patient: a rare form of presentation. Chemotherapy. 2003;49:209–211 in Google Scholar

[3] Dominguez DC, Antony SJ. Actinomyces and nocardia infections in immunocompromised and nonimmunocompromised patients. J Natl Med Assoc. 1999;91:35–39 Search in Google Scholar

[4] Fry RD, Birnbaum EH, Lacey DL. Actinomyces as a cause of recurrent perianal fistula in the immunocompromised patient. Surgery. 1992;111:591–594 Search in Google Scholar

[5] Richman M, Jeng A. Intra-abdominal co-infection with Mycobacterium bovis and Actinomyces in an AIDS patient: the first reported case and review. J Infect. 2007;55:e115–118 in Google Scholar

[6] Leach TD, Sadek SA, Mason JC. An unusual abdominal mass in a renal transplant recipient. Transpl Infect Dis. 2002;4:218–222 in Google Scholar

[7] Freland C, Massoubre B, Horeau JM, et al. Actinomycosis of the gallbladder due to Actinomyces naeslundii. J Infect. 1987;15:251–257 in Google Scholar

[8] Ormsby AH, Bauer TW, Hall GS. Actinomycosis of the cholecystic duct: case report and review. Pathology. 1998;30:65–67 in Google Scholar

[9] Wagenlehner FM, Mohren B, Naber KG, et al. Abdominal actinomycosis. Clin Microbiol Infect. 2003;9:881–885 in Google Scholar

[10] Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007;85:16–23 in Google Scholar

[11] Santos LD, Rogan KA, Kennerson AR. Cytologic diagnosis of suppurative cholecystitis due to Candida albicans and actinomyces. A report of 2 cases. Acta Cytol. 2004;48:407–410 in Google Scholar

[12] Hamid D, Baldauf JJ, Cuenin C, et al. Treatment strategy for pelvic actinomycosis: case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2000;89:197–200 in Google Scholar

[13] Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984;94:1198–1217 in Google Scholar PubMed

Published Online: 2011-4-8
Published in Print: 2011-6-1

© 2011 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 5.12.2023 from
Scroll to top button